AI assistant
Panacea Biotec Ltd. — Board/Management Information 2026
Apr 1, 2026
62573_rns_2026-04-01_f1979568-4c45-4645-ac92-900f0cfa6937.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [162 x 79] intentionally omitted <==
April 01, 2026
The Manager, Listing Department The National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol: PANACEABIO
BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 531349
Sub: Intimation of completion of tenure of Mr. Mukul Gupta as an Independent Director
Dear Sir / Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we would like to inform you that Mr. Mukul Gupta (DIN: 00254597), Independent Director of the Company has completed his second and final term of 5 (five) consecutive years as Independent Director on March 31, 2026 and accordingly he has ceased to be an Independent director of the Company. Consequently, he has also ceased to be the Chairperson / member of the Committees of the Board of Directors of the Company.
The Board of Directors and the Management of the Company express deep appreciation and gratitude to Mr. Mukul Gupta for his extensive contribution and guidance towards the business growth of the Company.
The details required to be disclosed under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed herewith as Annexure - A .
This is for your kind information and record please.
Thanking you, Sincerely yours, For Panacea Biotec Limited Digitally signed by ANKIT JAIN ANKIT JAIN Date: 2026.04.01 09:15:35 +05'30'
Ankit Jain General Manager – Legal & Company Secretary
Encl. As Above
Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Email: [email protected]
==> picture [162 x 79] intentionally omitted <==
Annexure – A
Details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure - Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025 CFD-POD2/I/3762/2026 dated January 30, 2026
| S. No. | Particulars | Description | |
|---|---|---|---|
| 1. | Reason for change viz. appointment,reappointment, resignation, removal,death or otherwise | Mr. Mukul Gupta has ceased to be IndependentDirector upon completion of his 2ndand finaltenure as an Independent Director of the Company | |
| 2. | Date ofappointment / re-appointment/cessation (as applicable)& term ofappointment/re- appointment | March 31, 2026 | |
| 3. | Brief profile, in case of appointment | Not Applicable | |
| 4. | Disclosure of relationships betweendirectors (in case of appointment of adirector) | Not Applicable |
ANKIT Digitally signed by ANKIT JAIN JAIN Date: 2026.04.01 09:15:58 +05'30'
Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Email: [email protected]